NOACU News

Eight SPACs went public this past week but no IPOs, as all three scheduled deals postponed or withdrew. New filing activity picked up, led by long-awaited delivery service unicorn DoorDash (DASH), and several launches indicate increased activity in the coming weeks. Three biotech IPOs were scheduled to go public this past week but didn’t make it to...read more

Natural Order Acquisition, a blank check company focusing on technologies and products related to sustainable plant-based food and beverages, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and a whole warrant to purchase one-half of a common share, exercisable at $11.50. The company originally planned to offer 25 million...read more

Updated Monday, 11/9. The US IPO market remains relatively quiet following election week, with three biotechs and one SPAC scheduled to raise $340 million in the week ahead. Oncology biotech IN8bio (INAB) plans to raise $75 million at a $325 million market cap. IN8bio is focused on developing cancer therapies by employing allogeneic, autologous...read more

Natural Order Acquisition, a blank check company focusing on technologies and products related to sustainable plant-based food and beverages, lowered the proposed deal size for its upcoming IPO on Thursday. The Weston, MA-based company now plans to raise $200 million by offering 20 million units at a price of $10. The company had previously filed to offer 25 million units at...read more